邢超凡,潘欣,何奔

• 1:上海市胸科医院心内科上海交通大学医学院附属胸科医院心内科

摘要(Abstract)：

人工瓣膜置换术后瓣周漏（PVL）是外科瓣膜置换术后较常见的并发症之一，临床表现为心功能不全和（或）溶血。相较而言，溶血多发生在机械金属瓣置换术后，发生率相对较低且易被忽视和误诊。经导管PVL封堵术是外科手术高危患者的替代手段，可改善心力衰竭症状、降低死亡率，但该方法对溶血的临床研究较少，且术后可发生封堵器诱发的溶血加重。本文就外科瓣膜置换术后PVL相关性溶血的机制和介入治疗进展予以系统综述。

关键词(KeyWords)： 瓣周漏;溶血;瓣膜置换术;介入

Abstract:

Keywords:

基金项目(Foundation): 上海市科委科研计划项目（17411970900）

作者(Author): 邢超凡,潘欣,何奔

参考文献(References)：

• [1] Kliger C, Eiros R, Isasti G, et al. Review of surgical prosthetic paravalvular leaks:diagnosis and catheter-based closure[J]. Eur Heart J, 2013, 34(9):638-649. DOI:10.1093/eurheartj/ehs347.
• [2] Rihal CS,Sorajja P,Booker JD,et al. Principles of percutaneous paravalvular leak closure[J]. JACC Cardiovasc Interv,2012,5(2):121-130. DOI:10.1016/j.jcin.2011.11.007.
• [3] Gafoor S, Steinberg DH, Franke J, et al. Tools and techniquesclinical:paravalvular leak closure[J]. EuroIntervention, 2014,9(11):1359-1363. DOI:10.4244/EIJV9I11A227.
• [4] Calvert PA,Northridge DB,Malik IS,et al. Percutaneous device closure of paravalvular leak:combined experience from the United Kingdom and Ireland[J]. Circulation,2016,134(13):934-944. DOI:10.1161/CIRCULATIONAHA.116.022684.
• [5] Millan X, Skaf S, Joseph L, et al. Transcatheter reduction of paravalvular leaks:a systematic review and meta-analysis[J].Can J Cardiol, 2015, 31(3):260-269. DOI:10.1016/j.cjca.2014.12.012.
• [6] Alkhouli M, Rihal CS, Zack CJ, et al. Transcatheter and surgical management of mitral paravalvular leak:long-term outcomes[J]. JACC Cardiovasc Interv, 2017, 10(19):1946-1956. DOI:10.1016/j.jcin.2017.07.046.
• [7] Taramasso M, Maisano F, Denti P, et al. Surgical treatment of paravalvular leak:long-term results in a single-center experience(up to 14 years)[J]. J Thorac Cardiovasc Surg, 2015, 149(5):1270-1275. DOI:10.1016/j.jtcvs.2014.12.041.
• [8] Sorajja P,Cabalka AK,Hagler DJ,et al. Percutaneous repair of paravalvular prosthetic regurgitation:acute and 30-day outcomes in 115 patients[J]. Circ Cardiovasc Interv, 2011, 4(4):314-321. DOI:10.1161/CIRCINTERVENTIONS.110.960955.
• [9] Ruiz CE,Jelnin V,Kronzon I,et al. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks[J]. J Am Coll Cardiol, 2011, 58(21):2210-2217. DOI:10.1016/j.jacc.2011.03.074.
• [10] Okuyama K, Jilaihawi H, Kashif M, et al. Percutaneous paravalvular leak closure for balloon-expandable transcatheter aortic valve replacement:a comparison with surgical aortic valve replacement paravalvular leak closure[J]. J Invasive Cardiol,2015,27(6):284-290.
• [11]韩喆，胡海波，吕建华，等.双导丝技术在瓣周漏介入治疗中的初步应用[J].中国介入心脏病学杂志，2022,30(8):580-584. DOI:10.3969/j.issn.1004-8812.2022.08.003.
• [12] Decesare W, Rath C, Hufnagel C. Hemolytic anemia of mechanical origin with aortic-valve prosthesis[J]. N Engl J Med,1965,272:1045-1050. DOI:10.1056/NEJM196505202722003.
• [13] Panaich SS, Maor E, Reddy G, et al. Effect of percutaneous paravalvular leak closure on hemolysis[J]. Catheter Cardiovasc Interv,2019,93(4):713-719. DOI:10.1002/ccd.27917.
• [14] Mecozzi G, Milano AD, De Carlo M, et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves:a prospective study[J]. J Thorac Cardiovasc Surg,2002,123(3):550-556. DOI:10.1067/mtc.2002.120337.
• [15] Gilchrist IC. Treating hemolysis due to perivalvular leaks:it is all about modifying micro-jets and not the volume of regurgitation[J]. Catheter Cardiovasc Interv,2019,93(4):720-721. DOI:10.1002/ccd.28183.
• [16] Ruiz CE, Hahn RT, Berrebi A, et al. Clinical trial principles and endpoint definitions for paravalvular leaks in surgical prosthesis:an expert statement[J]. J Am Coll Cardiol,2017,69(16):2067-2087. DOI:10.1016/j.jacc.2017.02.038.
• [17] Cruz-Gonzalez I, Rama-Merchan JC, Rodriguez-Collado J, et al. Transcatheter closure of paravalvular leaks:state of the art[J].Neth Heart J,2017,25(2):116-124. DOI:10.1007/s12471-016-0918-3.
• [18] Helmy T, Kumar S, Khan AA, et al. Review of prosthetic paravalvular leaks:diagnosis and management[J]. Curr Cardiol Rep,2022,24(10):1287-1297. DOI:10.1007/s11886-022-01744-y.
• [19] MillánX, Bouhout I, Nozza A, et al. Surgery versus transcatheter interventions for significant paravalvular prosthetic leaks[J]. JACC Cardiovasc Interv, 2017,10(19):1959-1969. DOI:10.1016/j.jcin.2017.08.013.
• [20] Wells JAt, Condado JF, Kamioka N, et al. Outcomes after paravalvular leak closure:transcatheter versus surgical approaches[J]. JACC Cardiovasc Interv, 2017,10(5):500-507. DOI:10.1016/j.jcin.2016.11.043.
• [21] Zhang Y, Pan X, Qu X, et al. Comparison of transcatheter and surgical treatment of paravalvular leak:results from a 5-year follow-up study[J]. Catheter Cardiovasc Interv,2019,94(2):E88-E95. DOI:10.1002/ccd.27371.
• [22] Kalogeras K, Ntalekou K, Aggeli K, et al. Transcatheter closure of paravalvular leak:multicenter experience and followup[J]. Hellenic J Cardiol,2021,62(6):416-422. DOI:10.1016/j.hjc.2021.02.002.
• [23]徐承义，苏晞，何亚峰.经导管介入封堵术治疗瓣周漏的现状[J].中国介入心脏病学杂志，2020,28(10):579-584.DOI:10.3969/j.issn.1004-8812.2020.10.008.
• [24] Sorajja P, Cabalka AK, Hagler DJ, et al. Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation[J].J Am Coll Cardiol,2011,58(21):2218-2224. DOI:10.1016/j.jacc.2011.07.041.
• [25] Smolka G, Pysz P, Ochala A, et al. Transcatheter paravalvular leak closure and hemolysis-a prospective registry[J].Arch Med Sci,2017,13(3):575-584. DOI:10.5114/aoms.2016.60435.
• [26] Kim JJ, Hijazi ZM. Clinical outcomes and costs of Amplatzer transcatheter closure as compared with surgical closure of ostium secundum atrial septal defects[J]. Med Sci Monit,2002,8(12):CR787-CR791.
• [27] Goktekin O, Vatankulu MA, Ozhan H, et al. Early experience of percutaneous paravalvular leak closure using a novel Occlutech occluder[J]. EuroIntervention, 2016, 11(10):1195-200.DOI:10.4244/EIJV11I10A237.
• [28] Gossl M, Rihal CS. Percutaneous treatment of aortic and mitral valve paravalvular regurgitation[J]. Curr Cardiol Rep,2013, 15(8):388. DOI:10.1007/s11886-013-0388-9.
• [29]潘欣，张佑俊，王承，等. Amplatzer血管塞封堵人工主动脉瓣周围漏15例报告[J].中华医学杂志，2014,94(42):3352-3353. DOI:10.3760/cma.j.issn.0376-2491.2014.42.017
• [30] Ruiz CE, Mathur AP. Paravalvular leak closure:time to standardize clinical endpoints?[J]. JACC Cardiovasc Interv,2016, 9(23):2427-2428. DOI:10.1016/j.jcin.2016.09.036.
• [31] Pilgrim T, Franzone A. Strategies for paravalvular prosthetic leak closure:competing or complementary?[J]. JACC Cardiovasc Interv, 2017, 10(19):1970-1972. DOI:10.1016/j.jcin.2017.08.034.
• [32] Otto CM, Nishimura RA,Bonow RO,et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J].J Am Coll Cardiol, 2021, 77(4):e25-e197. DOI:10.1016/j.jacc.2020.11.018.
• [33] Giblett JP, Rana BS, Shapiro LM, et al. Percutaneous management of paravalvular leaks[J]. Nat Rev Cardiol,2019, 16(5):275-285. DOI:10.1038/s41569-018-0147-0.